clinical trial · NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
VEXAS SyndromeMomelotinibGlucocorticoidsPlacebo
brief summary
This study will assess the efficacy and safety of momelotinib in participants with a diagnosis of VEXAS.
started
Aug 5, 2026
primary completion
Dec 6, 2028
completion
Jun 4, 2031
last updated
Jun 1, 2026
official title
A Randomized Phase 2/3, Double-blind, Placebo Controlled Adaptive Study Evaluating the Efficacy and Safety of Momelotinib in Participants With VEXAS Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol